Open AccessThe liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities
Author(s) -
Harsh Goel,
Farah Harmouch,
Kawish Garg,
Pooja Saraiya,
T Daly,
Ashish Kumar,
John T. Hippen
Publication year - 2020
Publication title -
european journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.881
H-Index - 102
eISSN - 1473-5687
pISSN - 0954-691X
DOI - 10.1097/meg.0000000000002021
Subject(s) - medicine , aspartate transaminase , alanine transaminase , bilirubin , liver disease , gastroenterology , liver injury , liver function tests , mortality rate , alanine aminotransferase , severity of illness , covid-19 , disease , alkaline phosphatase , infectious disease (medical specialty) , biochemistry , chemistry , enzyme
Coronavirus disease 2019 (COVID-19) has caused a global pandemic unprecedented in over a century, with ≈35 million cases, and more than 1 million deaths globally. Though predominantly a lower respiratory illness, other organ injuries are well-recognized. Among these, liver injury is of major interest.